Literature DB >> 12687383

Descending necrotizing mediastinitis following acute epiglottitis: a case report.

Ichiro Tateya1, Nobuya Fujiki, Kyosuke Kurata, Seiki Hasegawa, Hisayoshi Kojima.   

Abstract

Descending necrotizing mediastinitis occurs secondary to deep neck infection, and the primary focus of infection is mostly located in the tonsil, pharynx and carious tooth. DNM following acute epiglottitis is quite rare, with only one case reported. We treated an 84-year old female with an acute epiglottitis followed by DNM. She was successfully treated by drainages with cervical surgery combined with thoracotomy and cervical surgery.

Entities:  

Mesh:

Year:  2002        PMID: 12687383     DOI: 10.1007/s00405-002-0528-0

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  5 in total

1.  ["Descending necrotizing mediastinitis" due to deep neck infections. Incidence and management].

Authors:  A Sandner; J Börgermann; S Kösling; M B Bloching
Journal:  HNO       Date:  2006-11       Impact factor: 1.284

2.  Descending necrotizing mediastinitis as a complication of odontogenic infection.

Authors:  S Diamantis; H Giannakopoulos; J Chou; J Foote
Journal:  Int J Surg Case Rep       Date:  2011-02-01

3.  Update on necrotizing mediastinitis: causes, approaches to management, and outcomes.

Authors:  Annett Sandner; Jochen Börgermann
Journal:  Curr Infect Dis Rep       Date:  2011-06       Impact factor: 3.725

Review 4.  A case of an elderly patient treated for descending necrotizing mediastinitis.

Authors:  Atsushi Suga; Yoshimasa Inoue; Haruka Takeichi; Shunsuke Yamada; Masayuki Iwazaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-09-14

5.  Risk of acute epiglottitis in patients with preexisting diabetes mellitus: A population-based case-control study.

Authors:  Yao-Te Tsai; Ethan I Huang; Geng-He Chang; Ming-Shao Tsai; Cheng-Ming Hsu; Yao-Hsu Yang; Meng-Hung Lin; Chia-Yen Liu; Hsueh-Yu Li
Journal:  PLoS One       Date:  2018-06-11       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.